If you are interested in training on the new 10X Genomics instruments, please take the following survey. Group trainings will be conducted in November 2024.
Continue reading "10X Genomics Chromium X and Visium CytAssist Training Survey"Category: Molecular Informatics Core
Molecular Informatics Core
Cloud-based Learning Supp Summer 2023
NIH Cloud-Based Learning Supplement Update: Summer 2023 The completed module, A Cloud-Based Learning Module for Biomarker Discovery, launched in July with 11 other educational modules as part of the new NIGMS Sandbox. The Sandbox modules cover a variety of topics in biomedical data science including RNA-seq, proteomics, single cell ATAC-seq, and more. Manuscripts for each […]
Continue reading "Cloud-based Learning Supp Summer 2023"MIC Update
Molecular Informatics Core Update Summer 2023 Completion of Cloud-Based Learning Module and Launch of NIGMS Sandbox Last year the MIC received an administrative supplement to the RI-INBRE grant to complete a cloud-based training module for NIGMS. The completed module, A Cloud-Based Learning Module for Biomarker Discovery (CBLMBD), launched in July with 11 other educational modules as […]
Continue reading "MIC Update"Cloud-based Learning Supp 2022
NIH Cloud-Based Learning Supplement Award Announcement FY2022: Dr. Christopher Hemme, “Analysis of Biomedical Data for Biomarker Discovery” RI-INBRE was one of ten INBRE programs awarded (July 2022) an administrative supplement through the National Institutes of Health’s National Institute of General Medical Sciences, to build a cloud-based learning module to teach biomedical data science concepts in […]
Continue reading "Cloud-based Learning Supp 2022"NERLSCD 2022
Northeast Regional Laboratory Staff and Core Directors Annual Meeting Dr. Christopher Hemme attended the Northeast Regional Laboratory Staff and Core Directors (NERLSCD) Annual Meeting in October 2022. The NERLSCD meeting is an opportunity for core leaders and staff to network, meet with vendors, and get updated on new technologies and best practices in biological data science. The consensus among […]
Continue reading "NERLSCD 2022"Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023
NIH continues to work with the biomedical research community to promote effective and responsible management and sharing of scientific data generated from NIH-funded or conducted research. In an effort to reduce the burden of duplicative reporting expectations, NIH is informing the research community of its intent to establish a single Plan submission requirement for research […]
Continue reading "Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023"Announcing The NIH Long COVID Computational Challenge (L3C)
Join the challenge to develop, train, and test models to aid in predicting the susceptibility to and likelihood of developing PASC/Long COVID in patients with SARS-CoV-2 infection. Long COVID, can affect anyone, including children, and it can develop in people who had asymptomatic, mild, or severe COVID-19. To complement the National Institutes of Health (NIH) […]
Continue reading "Announcing The NIH Long COVID Computational Challenge (L3C)"MIC Virtual Open House
In preparation for our upcoming INBRE renewal, the MIC will be holding a virtual open house event on Wednesday, Aug 10 1-2 PM (Zoom link). Dr. Hemme will be presenting a short talk on the current state of the Core and what factors will influence the future of the Core. Specifically, we will discuss current […]
Continue reading "MIC Virtual Open House"Sequencing Update
Sequencing Update Winter 2023 It has been a year and a half since the merger of the URI Genomics and Sequencing Center (GSC) with the RI-INBRE Bioinformatics Core to form the RI-INBRE Molecular Informatics Core (MIC), we have closely monitored usage to ensure that we are providing sufficient services to our customers. Our two primary […]
Continue reading "Sequencing Update"Methotrexate VR
Methotrexate is a folate inhibitor that targets the dihydrofolate reductase (DHFR) enzyme, resulting in interference with nucleotide synthesis and cellular repair. For this reason, methotrexate is used as an anti-cancer drug. The goal of this app is to demonstrate the activity of methotrexate when interacting with DHFR in a virtual environment that requires the user […]
Continue reading "Methotrexate VR"